BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Anticancer prodrugs
,
Fenofibrate
,
rs7903146
,
PRKCA
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Sf- 1
Summary
General Info
Curated Studies
Most Correlated Studies
Adrenocortical cancer H295R/TR SF-1 cells overexpressing SF-1, SF-1 siRNA, or REST siRNA
Adrenocortical cancer H295R/TR SF-1 cells with conditional SF-1 overexpression
Adrenocortical, cervical and breast cancer cell lines in response to LBH589 treatment
Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Drug Matrix In Vitro Toxicogenomic Study - Rat Hepatocytes [Affymetrix]
Explore Curated Studies Results
Literature
Most Relevant Literature
The role of steroidogenic factor 1 (SF-1) in steroidogenic cell function of the testes and ovaries o…
Case Report: Longitudinal follow-up and testicular sperm extraction in a patient with a pathogenic N…
Comparison of activity, structure, and dynamics of SF-1 and LRH-1 complexed with small molecule modu…
CRISPR/Cas9-mediated activation of NR5A1 steers female human embryonic stem cell-derived bipotential…
MicroRNA-92a-3p Inhibits Cell Proliferation and Invasion by Regulating the Transcription Factor 21/S…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Wi…
A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1…
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 S…
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1…
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ